3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Very obese fare worse after colon cancer diagnosis

CancerNov 15, 06

Obese patients are more likely to have a recurrence of colon cancer than their normal-weight counterparts and face an increased risk of dying from the disease, a new study shows.

While it’s not clear that losing weight would improve their prognosis, Dr. James J. Dignam of the University of Chicago and colleagues note, healthy lifestyle changes would probably have other beneficial effects for obese colon cancer patients.

There is strong evidence that being obese, defined as having a body mass index (BMI) of 30 or greater, both increases the likelihood of developing colon cancer and worsens prognosis for individuals diagnosed with the disease, Dignam and his team report in the Journal of the National Cancer Institute.

To better understand the relationship between a patient’s BMI and the outcome of chemotherapy for colon cancer, Dignam and his team looked at 4,288 colon cancer patients participating in two large nationwide clinical trials. The patients underwent surgery following a diagnosis of Dukes B or C colon cancer and all of the patients were randomly assigned to a chemotherapy regimen.

Subjects with a BMI of 35 or greater (defined as very obese) had a 38-percent risk of a tumor recurrence compared with normal weight individuals (those with a BMI of 18.5 to 24.9), the researchers found. The very obese were also 28 percent more likely to die during the 11.2-year follow-up period.

Underweight patients also had an elevated risk of death compared with those of normal weight, but most of their 49 percent increased death risk was due to causes unrelated to colon cancer.

The increased risk among the very obese could be related to the interplay between insulin, insulin-like growth factors and proteins that bind to these growth factors, Dignam and his colleagues suggest.

While more research is needed to determine if obese colon cancer patients will do better if they lose weight, they add, “physicians might use the frequent encounters they have with these patients to counsel them regarding the possibility of modifying this risk with lifestyle changes.”

In any case, the researchers note, helping obese colon cancer patients eat better and become more active will likely have other benefits.

SOURCE: Journal of the National Cancer Institute, November 15, 2006.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site